Infectious Diseases News and Research

RSS

Researchers use single-cell sequencing to identify cell types that occur in pancreatic tumors

Led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and by HonorHealth Research and Innovation Institute, an international team of researchers have described in detail the individual cells that comprise the pancreatic cancer microenvironment, a critical step in devising new treatment options for patients with this aggressive and difficult-to-treat disease.

1 Oct 2020

Investigational mRNA vaccine to prevent SARS-CoV-2 shows promise in older adults

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

30 Sep 2020

SARS-CoV-2 D614G variant enhances infectivity, replication and transmission

Researchers in the United States and Japan have conducted a study showing a common mutation in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVD-19) - enhances the infectivity, replication, and early transmission of the virus.

30 Sep 2020

Researchers develop research model to understand the impact of coronavirus on lungs

Scientists at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL) and the Center for Regenerative Medicine (CReM) joined forces to develop the most relevant research model possible for understanding how the coronavirus virus impacts the lungs, by engineering living, "breathing" human lung cells from stem cells for the task.

30 Sep 2020

Researchers identify a new method to produce miniaturized antibodies

Researchers at the University of Bath in the UK and biopharma company UCB have found a way to produce miniaturized antibodies, opening the way for a potential new class of treatments for diseases.

30 Sep 2020

Sleep apnea increases risk of severe COVID 19

Coronavirus disease (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A subset of COVID-19 patients face a severe form of the disease with hospitalization, respiratory failure, or death. Severe COVID-19 is primarily characterized by respiratory distress, and the common risk factors are older age, obesity, cardiovascular disease, diabetes, and poor lung function.

29 Sep 2020

Genetic defects in patients' immune system may underlie severe COVID-19

Worldwide, otherwise healthy adolescents and young people without underlying conditions are sometimes severely affected by COVID-19, with the viral infection in the worst cases quickly becoming life-threatening. But why is this happening?

29 Sep 2020

Fructose intake may exacerbate inflammatory bowel disease, study reveals

Diet remains an important part of disease prevention and management, and a new study suggests that consumption of fructose may worsen intestinal inflammation common to inflammatory bowel diseases (IBD).

29 Sep 2020

Computer model unravels mystery behind severe inflammation in people with COVID-19

A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation?

29 Sep 2020

How might India's monsoon season impact COVID-19 ?

A new study, by two Goethe University Frankfurt researchers, published on the preprint server medRxiv* in September 2020 explores the relationship between the monsoon season, the chances of exposure to ultraviolet B (UVB) radiation, and the COVID-19 mortality.

29 Sep 2020

Study shows how Zika virus degrades key protein involved in neurological growth

In a study published in Autophagy, researchers at the University of Maryland (UMD) shed new light on how Zika virus hijacks our own cellular machinery to break down a protein that is essential for neurological development and cellular communication, getting it to "eat itself."

29 Sep 2020

New agreements to ensure all countries have fair access to COVID-19 rapid diagnostic tests

A set of agreements to make available, for low and middle-income countries, affordable, high-quality COVID-19 antigen rapid tests were today announced by the Access to COVID-19 Tools (ACT) Accelerator.

28 Sep 2020

Saliva tests could be an effective approach for detecting asymptomatic COVID-19

Testing self-collected saliva samples could offer an easy and effective mass testing approach for detecting asymptomatic COVID-19.

28 Sep 2020

Young adults now driving force behind the ongoing COVID-19 pandemic says CDC

The Centers for Disease Control and Prevention (CDC) has released a report stating that the ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is on the rise among young adults and this rise is preventing the pandemic from abating.

27 Sep 2020

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

As we improve our understanding of immune responses and correlates of protection against the severe acute respiratory syndrome coronavirus (SARS-CoV-2), two UK researchers emphasize that we will probably utilize different assays to tackle specific questions. Their commentary is published in the prestigious journal Lancet Infectious Diseases.

27 Sep 2020

Masks and face coverings are effective in reducing the spread of airborne particles

Laboratory tests of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles emitted during breathing, talking and coughing.

26 Sep 2020

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.

25 Sep 2020

Ultrapotent antibody mix locks infection machinery, inhibits SARS-CoV-2 attachment to cells

A mix of ultrapotent antibodies from recovered COVID-19 patients has been shown to recognize and lock down the infection machinery of the pandemic coronavirus and keep it from entering cells. Each of the antibody types performs these overlapping tasks slightly differently.

25 Sep 2020

UMass Amherst epidemiologist receives NIH grant to develop new tick surveillance method

A University of Massachusetts Amherst infectious disease epidemiologist has received a grant from the National Institutes of Health to develop a new surveillance method to better identify specific locations with the highest risk for tick-borne disease transmission.

25 Sep 2020

New diagnostic tool may allow on-the-spot detection of coronavirus infection

Scientists at the University of Warwick have demonstrated that a potential diagnostic tool for detecting Covid-19 using sugars will work with a virus rather than just its proteins, a significant step in making it a viable test in future.

25 Sep 2020

Infectious Diseases News and Research

Researchers use single-cell sequencing to identify cell types that occur in pancreatic tumors

Investigational mRNA vaccine to prevent SARS-CoV-2 shows promise in older adults

SARS-CoV-2 D614G variant enhances infectivity, replication and transmission

Researchers develop research model to understand the impact of coronavirus on lungs

Researchers identify a new method to produce miniaturized antibodies

Sleep apnea increases risk of severe COVID 19

Genetic defects in patients' immune system may underlie severe COVID-19

Fructose intake may exacerbate inflammatory bowel disease, study reveals

Computer model unravels mystery behind severe inflammation in people with COVID-19

How might India's monsoon season impact COVID-19 ?

Study shows how Zika virus degrades key protein involved in neurological growth

New agreements to ensure all countries have fair access to COVID-19 rapid diagnostic tests

Saliva tests could be an effective approach for detecting asymptomatic COVID-19

Young adults now driving force behind the ongoing COVID-19 pandemic says CDC

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

Masks and face coverings are effective in reducing the spread of airborne particles

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

Ultrapotent antibody mix locks infection machinery, inhibits SARS-CoV-2 attachment to cells

UMass Amherst epidemiologist receives NIH grant to develop new tick surveillance method

New diagnostic tool may allow on-the-spot detection of coronavirus infection

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News